1Lanza F. Bardhan KD. Perdomo C,et al. Efficacy of rabeprazole once daily for acid-related diseases. Dig Dis Sci. 2001.46(3) : 546-587.
2Patti MG. Diener U. Tamburini A, et al. Role of esophageal function tests in diagnosis of gastroesophageal reflux disease. Dig Dis Sci . 2001 ,46(3) : 597-602.
3Schenk BE. Kuipers EJ. Klinkenberg-Knol EC. et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol. 1997,92 ( 11 ) : 1959-1960.
4GalmicheJP, BarthelemyP, HmelinB. Treating the symptoms of gastro-oesophageal reflux disease za double-blind comparison of omprazole and cisapride . Aliment Pharmacol Ther.1997. 11 (4) :765-773.
5Caro J J, Salas M, Ward A. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhihitors lansoprazole .raheprzole and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. Clln Ther.2001. 23(7): 998-1017.
6Van Rensburg CJ, Bardhan KD. No clinical benefit of adding cisapride to pant oprazole for treatment of gastro-oesopbageal reflux disease. Eur J Gastroenterol Hepatol. 2001,13(8):909-914.
7McDougall NI, Johnston BT. Kee F et al. Natural history of reflux oesophagltis:a 10 year follow up of its effect on patient symptomatology and quality of life. Gut,1996,38(4):481-486.
8Drossman DA. The functional gastrointestinal disorders and Rome Ⅱ process. Gut,1999,4S(suppl Ⅱ) :1-5.
